ACUTE ORAL TOLERABILITY AND ANTI-INFLAMMATORY ACTIVITY OF 1,3,4-THIADIAZOLE DERIVATIVES: A SECONDARY ANALYSIS

Authors

  • Basirova Guzel Rasulovna Andijan State Medical Institute image/svg+xml Author

Keywords:

1,3,4-thiadiazole; anti-inflammatory activity; acute oral toxicity; carrageenan; dose–response; secondary analysis.

Abstract

Functionally substituted 1,3,4-thiadiazoles have shown activity in preliminary in vivo inflammation screens, while their acute tolerability has been described in mice. Objective: To synthesise published safety and efficacy observations into a transparent early-stage prioritisation framework. Methods: A descriptive secondary analysis was conducted using two 2024 reports on acute oral dosing and carrageenan-induced edema. Mortality, body-mass observations, dose levels and published percentage edema inhibition were extracted. No new animal work or statistical hypothesis tests were performed. Results: The original report documented 0/5 deaths per studied compound after a single oral dose of 2,000 mg/kg, with transient clinical signs. The same publications reported anti-inflammatory effects at 50 and 100 mg/kg. For the bis(sulfanediyl) diacetohydrazide, edema inhibition at 24 hours was 40.0% at 50 mg/kg versus 30.5% at 100 mg/kg; for the diethyl diacetate, corresponding figures were 34.6% and 23.4%. These descriptive observations are not evidence of a monotonic dose–response. Conclusion: The series merits confirmatory pharmacological investigation, but the mortality-based acute screen does not establish chronic safety or therapeutic index, and efficacy findings need replication using a documented statistical plan.

References

1.Basirova, G. R., Makhmudov, L. U., Usmonov, Sh. T., Tagayalieva, N. A., & Babayev, B. N. (2024). Определение острой токсичности и воспалительной активности производных 1,3,4-тиадиазолов [Determination of acute toxicity and inflammatory activity of 1,3,4-thiadiazole derivatives]. Journal of IQRO, 13(1).

2.Basirova, G. R., Zhaloliddinov, F. Yu., Makhmudov, L. U., & Babayev, B. N. (2024). Synthesis and pharmacological evaluation of new 1,3,4-thiadiazole derivatives. Science and Innovation, 3(11), 139–143. https://doi.org/10.5281/zenodo.14251419

3.OECD. (2002). Test No. 420: Acute Oral Toxicity—Fixed Dose Procedure. OECD Publishing. https://doi.org/10.1787/9789264070943-en

4.Basirova, G. R. (2024). Молекулярный докинг производных 1,3,4 тиадиазола [Molecular docking of 1,3,4-thiadiazole derivatives]. Academic Research in Modern Science, 121–122. https://doi.org/10.5281/zenodo.13968337

Downloads

Published

2026-11-05